– Compelling PAX-D results guided Alto’s acquisition of ALTO-207, designed to induce rapid antidepressant effects while mitigating dose-limiting adverse events of pramipexole – – Alto plans to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback